Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe erythema multiforme responding to interferon alfa.

Pedram Geraminejad1, Hobart W Walling, Michael D Voigt

  • 1Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Journal of the American Academy of Dermatology
|January 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical Large Vessel Vasculitis Presenting With Cholestatic Liver Abnormalities: Case-Based Review.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2020
Same author

Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.

Journal of hepato-biliary-pancreatic sciences·2019
Same author

Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Gastroenterology·2019
Same author

Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.

Hepatology (Baltimore, Md.)·2018
Same author

Inflammatory sebotropic reaction associated with kava kava ingestion.

JAAD case reports·2018
Same author

Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.

Gastroenterology·2018

Hepatitis C virus is rarely linked to Erythema Multiforme (EM). A severe EM case, previously cleared by interferon, showed dramatic response to interferon and ribavirin therapy, even with undetectable viral load.

Area of Science:

  • Dermatology
  • Hepatology
  • Immunology

Background:

  • Erythema multiforme (EM) is an immune-mediated condition, typically triggered by infections like herpes simplex virus.
  • Hepatitis C virus (HCV) is an uncommon cause of EM.
  • Severe, refractory EM poses a significant clinical challenge.

Observation:

  • A 37-year-old male presented with an 8-year history of severe EM resistant to multiple treatments.
  • The patient had a prior, unexplained remission of EM during interferon treatment for HCV 6 years earlier.
  • HCV viral titer was undetectable at the time of re-initiation of therapy.

Findings:

  • Re-initiation of interferon and ribavirin therapy led to a dramatic and sustained clearance of EM within 2 months.
  • This case represents the third documented instance of EM responding to interferon therapy globally.

Related Experiment Videos

  • It is the first reported case where EM resolved with interferon despite an undetectable HCV viral load prior to treatment.

    • Implications:

    • Interferon therapy may be a viable treatment option for select cases of severe, refractory Erythema Multiforme, particularly those with a history of Hepatitis C virus infection.
    • The mechanism of EM clearance by interferon, even in the absence of detectable viremia, warrants further investigation.
    • This case highlights the complex interplay between viral infections, immune responses, and dermatological manifestations.